Quarterly report pursuant to Section 13 or 15(d)

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT

v3.21.2
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT - USD ($)
Total
Series A Preferred Stock [Member]
Series B Preferred Stock [Member]
Series C Preferred Stock [Member]
Series D Preferred Stock [Member]
Common Stock
Additional Paid-In Capital
Treasury Stock
Retained Earnings (Accumulated Deficit)
Balance, shares at Mar. 31, 2020   500,000 1,160,240 2,318,012   49,348,707      
Balance, amount at Mar. 31, 2020 $ (5,729,400) $ 500 $ 1,200 $ 2,300 $ 0 $ 49,300 $ 200,092,800 $ (3,968,100) $ (201,907,400)
Proceeds from sale of units of common stock and warrants 2,790,600                
for cash in private placement, shares           125,000      
for cash in private placement, amount 50,000 0 0 0 0 $ 200 49,800 0 0
Net proceeds from sale of common stock under equity line, shares           6,201,995      
Net proceeds from sale of common stock under equity line, amount 2,747,500 0 0 0 0 $ 6,200 2,741,300 0 0
Issuance of common stock at fair value for professional services, shares           233,645      
Issuance of common stock at fair value for professional services, amount 125,000 0 0 0 0 $ 200 124,800 0 0
Purchase Plan, shares           28,125      
Purchase Plan, amount 12,600 0 0 0 0 $ 0 12,600 0 0
Expenses related to S-3 registration statement for warrant shares (29,400) 0 0 0 0 0 (29,400) 0 0
Accrued dividends on Series B Preferred stock (335,800) 0 0 0 0 0 (335,800) 0 0
Stock-based compensation expense 674,600 0 0 0 0 0 674,600 0 0
Net loss for the quarter ended June 30, 2020 (3,126,800) $ 0 $ 0 $ 0 0 $ 0 0 0 (3,126,800)
Balance, shares at Jun. 30, 2020   500,000 1,160,240 2,318,012   55,937,472      
Balance, amount at Jun. 30, 2020 (5,611,700) $ 500 $ 1,200 $ 2,300 0 $ 55,900 203,330,700 (3,968,100) (205,034,200)
Balance, shares at Mar. 31, 2020   500,000 1,160,240 2,318,012   49,348,707      
Balance, amount at Mar. 31, 2020 $ (5,729,400) $ 500 $ 1,200 $ 2,300 $ 0 $ 49,300 200,092,800 (3,968,100) (201,907,400)
Issuance of common stock upon exercise of options for cash, shares 1,516,768                
Balance, shares at Mar. 31, 2021   500,000 1,131,669 2,318,012 402,149 180,751,234      
Balance, amount at Mar. 31, 2021 $ 91,978,400 $ 500 $ 1,100 $ 2,300 $ 400 $ 180,800 315,603,100 (3,968,100) (219,841,700)
Proceeds from sale of units of common stock and warrants 0                
Purchase Plan, shares           16,251      
Purchase Plan, amount 31,600 0 0 0 0 $ 0 31,600 0 0
Accrued dividends on Series B Preferred stock (361,800) 0 0 0 0 0 (361,800) 0 0
Net loss for the quarter ended June 30, 2020 (7,744,500) 0 0 0 0 0 0 0 (7,744,500)
Stock-based compensation expense (including ESPP) 590,400 0 0 0 0 $ 0 590,400 0 0
Proceeds from exercise of warrants, shares           1,516,768      
Proceeds from exercise of warrants, amount 1,109,700 0 0 0 $ 0 $ 1,500 1,108,200 0 0
Conversion of Series D Preferred stock into common stock, shares         (402,149) 9,249,427      
Conversion of Series D Preferred stock into common stock, amount 0 0 0 0 $ (400) $ 9,200 (8,800) 0 0
Issuance of common stock upon cashless exercise of options, shares           82,504      
Issuance of common stock upon cashless exercise of options, amount 100 0 0 0 0 $ 100 0 0 0
Issuance of common stock upon exercise of options for cash, shares           15,824      
Issuance of common stock upon exercise of options for cash, amount 12,900 $ 0 $ 0 $ 0 0 $ 0 12,900 0 0
Balance, shares at Jun. 30, 2021   500,000 1,131,669 2,318,012   191,632,008      
Balance, amount at Jun. 30, 2021 $ 85,616,800 $ 500 $ 1,100 $ 2,300 $ 0 $ 191,600 $ 316,975,600 $ (3,968,100) $ (227,586,200)